Applied DNA Sciences Inc EBIT Margin 2010-2023 | APDN
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Applied DNA Sciences Inc (APDN) over the last 10 years. The current EBIT profit margin for Applied DNA Sciences Inc as of December 31, 2023 is .
| Applied DNA Sciences Inc EBIT Margin Historical Data |
| Date |
TTM Revenue |
TTM EBIT |
EBIT Margin |
| 2023-12-31 |
$0.01B |
$-0.01B |
-155.56% |
| 2023-09-30 |
$0.01B |
$-0.01B |
-84.62% |
| 2023-06-30 |
$0.02B |
$-0.01B |
-68.75% |
| 2023-03-31 |
$0.02B |
$-0.01B |
-64.71% |
| 2022-12-31 |
$0.02B |
$-0.01B |
-52.63% |
| 2022-09-30 |
$0.02B |
$-0.01B |
-77.78% |
| 2022-06-30 |
$0.02B |
$-0.02B |
-88.24% |
| 2022-03-31 |
$0.02B |
$-0.02B |
-100.00% |
| 2021-12-31 |
$0.01B |
$-0.02B |
-125.00% |
| 2021-09-30 |
$0.01B |
$-0.01B |
-130.00% |
| 2021-06-30 |
$0.01B |
$-0.01B |
-171.43% |
| 2021-03-31 |
$0.01B |
$-0.01B |
-240.00% |
| 2020-12-31 |
$0.00B |
$-0.01B |
-433.33% |
| 2020-09-30 |
$0.00B |
$-0.01B |
-650.00% |
| 2020-06-30 |
$0.00B |
$-0.01B |
-275.00% |
| 2020-03-31 |
$0.01B |
$-0.01B |
-150.00% |
| 2019-12-31 |
$0.01B |
$-0.01B |
-150.00% |
| 2019-09-30 |
$0.01B |
$-0.01B |
-150.00% |
| 2019-06-30 |
$0.01B |
$-0.01B |
-200.00% |
| 2019-03-31 |
$0.00B |
$-0.01B |
-300.00% |
| 2018-12-31 |
$0.00B |
$-0.01B |
-275.00% |
| 2018-09-30 |
$0.00B |
$-0.01B |
-275.00% |
| 2018-06-30 |
$0.00B |
$-0.01B |
-275.00% |
| 2018-03-31 |
$0.01B |
$-0.01B |
-220.00% |
| 2017-12-31 |
$0.01B |
$-0.01B |
-240.00% |
| 2017-09-30 |
$0.01B |
$-0.01B |
-260.00% |
| 2017-06-30 |
$0.01B |
$-0.01B |
-200.00% |
| 2017-03-31 |
$0.01B |
$-0.01B |
-240.00% |
| 2016-12-31 |
$0.01B |
$-0.01B |
-240.00% |
| 2016-09-30 |
$0.01B |
$-0.01B |
-220.00% |
| 2016-06-30 |
$0.01B |
$-0.01B |
-128.57% |
| 2016-03-31 |
$0.01B |
$-0.01B |
-100.00% |
| 2015-12-31 |
$0.01B |
$-0.01B |
-77.78% |
| 2015-09-30 |
$0.01B |
$-0.01B |
-88.89% |
| 2015-06-30 |
$0.01B |
$-0.01B |
-183.33% |
| 2015-03-31 |
$0.01B |
$-0.01B |
-220.00% |
| 2014-12-31 |
$0.00B |
$-0.01B |
-300.00% |
| 2014-09-30 |
$0.00B |
$-0.01B |
-300.00% |
| 2014-06-30 |
$0.00B |
$-0.01B |
-275.00% |
| 2014-03-31 |
$0.00B |
$-0.01B |
-300.00% |
| 2013-12-31 |
$0.00B |
$-0.01B |
-400.00% |
| 2013-09-30 |
$0.00B |
$-0.01B |
-500.00% |
| 2013-06-30 |
$0.00B |
$-0.01B |
-1000.00% |
| 2013-03-31 |
$0.00B |
$-0.01B |
-800.00% |
| 2012-12-31 |
$0.00B |
$-0.01B |
-350.00% |
| 2012-09-30 |
$0.00B |
$-0.01B |
-233.33% |
| 2012-06-30 |
$0.00B |
$-0.01B |
-300.00% |
| 2012-03-31 |
$0.00B |
$-0.01B |
-450.00% |
| 2011-12-31 |
$0.00B |
$-0.01B |
-900.00% |
| 2011-09-30 |
$0.00B |
$-0.01B |
inf% |
| 2011-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2011-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2010-12-31 |
$0.00B |
$-0.01B |
inf% |
| 2010-09-30 |
$0.00B |
$-0.01B |
inf% |
| 2010-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2010-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2009-12-31 |
$0.00B |
$-0.01B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Industrial Products |
Protection - Safety Equipment & Services |
$0.003B |
$0.013B |
|
Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.
|
